drugset / Trial / NCT00169585

Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA)

NCT00169585

Phase 3 Completed 240 enrolled GlaxoSmithKline
RandomizedParallel-groupOpen-labelOther

Summary

Multicentric, national, prospective, parallel group, controlled. The Subjects in every center will be randomized and assigned to the pharmacologic arm or the one with the biochemical monitoring

Timeline

Start
2005-03
Primary completion
2007-04
Completion
2007-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Levofloxacin Small molecule Oral

Indications